Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma by Herrmann, E., Marschner, N., Grimm, M. O., Ohlmann, C. H., Hutzschenreuter, U., Overkamp, F., Groschek, M., Blumenstengel, K., Pühse, G., Steiner, T.

Get full text

6155 POSTER Panitumumab in Patients With Chemorefractory Wild-type KRas MCRC – Results of a Second Interim Analysis From a Community-based Non-interventional Cohort Study (VECTOR)... by Scheuer, B, Kroening, K, Lerchenmueller, C, Stauch, M, Boecher, E, Hellebrand, E, Kuhn, A, Groschek, M

Get full text

Hemoglobin levels that trigger erythropoiesis-stimulating agent treatment decisions for cancer-associated anemia - examination of practice in Germany by Steinmetz, T., Totzke, U., Söling, U., Groschek, M., Mittermüller, J., Schweigert, M., Tesch, H., Nawka, S., Schmitz, S., Tsamaloukas, A.

Get full text

Home parenteral nutrition (HPN) using individually compounded PN via A 7/8/9-Multi-chamber system versus PN via 2/3-chamber bags in subjects with metastatic or localized solid tumo... by Al-Batran, S.-E., Roetzer, I., Wohn, L., Blau, W., Zander, T., Luley, K.B., Ivanyi, P., Hofheinz, R.-D., Groschek, M., Kreiss-Sender, J., Baur, C., Wolff, T., Wenning, B., Decker-Baumann, C., Bouymayan, S., Sookthai, D., Schaaf, M., Riedel, J., Goetze, T.O., Haag, G.M.

Get full text

Hemoglobin levels that trigger erythropoiesis-stimulating agent treatment decisions for cancer-associated anemia - examination of practice in Germany by Steinmetz, T., Totzke, U., Söling, U., Groschek, M., Mittermüller, J., Schweigert, M., Tesch, H., Nawka, S., Schmitz, S., Tsamaloukas, A.

Get full text